Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidence.

Autor: Reinecke MJ; Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany., Ahlers G; Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany., Burchert A; Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany., Eilsberger F; Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany., Flux GD; Department of Physics, Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK., Marlowe RJ; Spencer-Fontayne Corporation, Jersey City, NJ, 07304-1901, USA., Mueller HH; Institute for Medical Bioinformatics and Biostatistics, Philipps University of Marburg, Marburg, Germany., Reiners C; Department of Nuclear Medicine, University Hospital Wuerzburg, Wuerzburg, Germany., Rohde F; Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany., van Santen HM; Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Luster M; Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany. luster@med.uni-marburg.de.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Jul; Vol. 49 (9), pp. 3247-3256. Date of Electronic Publication: 2022 Mar 23.